Report Content
Chapter 1 Methodology and Scope
1.1 Market scope and definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates and calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of blood disorders
3.2.1.2 Growing demand for point-of-care testing
3.2.1.3 Technological advancements in hematology testing
3.2.2 Industry pitfalls and challenges
3.2.2.1 High cost of advanced hematocrit devices
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technology landscape
3.6 Porter’s analysis
3.7 PESTEL analysis
3.8 Gap analysis
3.9 Future market trends
3.10 Value chain analysis
Chapter 4 Competitive Landscape, 2024
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2034 ($ Mn)
5.1 Key trends
5.2 Instruments
5.2.1 Hematocrit test analyzer
5.2.2 Hematocrit test meter
5.3 Reagents and consumables
Chapter 6 Market Estimates and Forecast, By Modality, 2021 – 2034 ($ Mn)
6.1 Key trends
6.2 Laboratory-based testing
6.3 Point-of-care (POC) testing
Chapter 7 Market Estimates and Forecast, By Application, 2021 – 2034 ($ Mn)
7.1 Key trends
7.2 Anemia
7.3 Congenital heart diseases
7.4 Polycythemia vera
7.5 Other applications
Chapter 8 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)
8.1 Key trends
8.2 Hospitals
8.3 Diagnostic laboratories
8.4 Ambulatory surgical centers
8.5 Other end users
Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Netherlands
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
Chapter 10 Company Profiles
10.1 MENARINI Group
10.2 Abbott
10.3 BIO-RAD
10.4 Boule
10.5 Danaher
10.6 Diatron
10.7 EKF Diagnostics
10.8 Roche
10.9 HORIBA Medical
10.10 Mindray
10.11 NIHON KOHDEN
10.12 Nova Biomedical
10.13 SENSA CORE
10.14 SIEMENS Healthineers
10.15 Sysmex
